Skip to content

Clinical trials

Completed Phase 2 Neuromuscular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromuscular Diseases Phase: Phase 2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20162
20171
20181
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amylyx Pharmaceuticals Inc.1
Avidity Biosciences, Inc.1
Capricor Inc.1
Craig McDonald, MD1
Emory University1
Fulcrum Therapeutics1
Michelle Ramsay1
Neuraltus Pharmaceuticals, Inc.1
Scholar Rock, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromuscular Diseases9
Nervous System Diseases4
Amyotrophic Lateral Sclerosis3
Muscular Dystrophies3
Neurodegenerative Diseases3
Central Nervous System Diseases2
Genetic Diseases, Inborn2
Motor Neuron Disease2
Muscular Diseases2
Muscular Disorders, Atrophic2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.